13 – 15/09/2024,

MONTANA Hotel Karpenisi

IASIS PHARMA participated in the HELLENIC OSTEOPOROSIS FOUNDATION CONFERENCE (HELIOS), held in Karpenisi, at the Montana Hotel, from September 13 to 15, 2024.

The Panhellenic conference of the Hellenic Osteoporosis Foundation (ΗELIOS) is the main scientific event of the HELIOS Foundation, involving participations of medical specialties dealing with Osteoporosis and Metabolic Diseases, to be informed about the latest developments in the subjects of metabolic bone diseases.

At IASIS PHARMA exhibition stand, the following products were presented:

  • COVED®: Alendronic Acid 70mg/ Cholecalciferol 5.600IU, (box of 4 tabs) for monthly treatment.
  • Etrozac®: Etoricoxib: Etrozac® 20 tabs x 60 mg, Etrozac® 14 tabs x 90 mg, Etrozac® 20 tabs x 90 mg, Etrozac® 20 tabs x 120 mg.
  • Calciform D3®: Effervescent tablets 500mg Calcium and 880 IU Vitamin D3, (Box of 30 eff. tabs).
  • MAG–IASIS®: Τhe first uniquely effective combination of 1193.57 mg Magnesium citrate & 667.56 mg Magnesium aspartate, equivalent to 243 mg Magnesium, indicated for magnesium deficiency, in the form of 40 effervescent tablets.

 

%ce%b5%ce%bb%ce%b9%ce%bf%cf%83-2-copy